Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells

Nathan De Beule; Eline Menu; Mathieu J.M. Bertrand; Mérédis Favreau; Elke De Bruyne; Ken Maes; Kim De Veirman; Magdalena Radwanska; Afshin Samali; Stefan Magez; Karin Vanderkerken; Carl De Trez

doi:10.18632/oncotarget.25336

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells

PDF | How to cite

Oncotarget. 2018; 9:22871-22871. https://doi.org/10.18632/oncotarget.25336

Metrics: PDF 1539 views | ?

Nathan De Beule^1,*, Eline Menu^1,*, Mathieu J.M. Bertrand^2,3, Mérédis Favreau^1,4,9, Elke De Bruyne¹, Ken Maes¹, Kim De Veirman¹, Magdalena Radwanska^3,4, Afshin Samali^5,6, Stefan Magez^7,8, Karin Vanderkerken¹ and Carl De Trez⁸

¹Department of Hematology and Immunology-Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium
²In Inflammation Research Center, VIB, Zwijnaarde-Ghent, Belgium
³Department of Biomedical Molecular Biology, Ghent University, Zwijnaarde-Ghent, Belgium
⁴Department of Molecular Immunology and Inflammation, VIB Inflammation Research Center, Ghent University, Ghent, Belgium
⁵Apoptosis Research Centre, NUI Galway, Ireland
⁶School of Natural Sciences, NUI Galway, Ireland
⁷Ghent University Global Campus, Yeonsu-Gu, Incheon, South Korea
⁸Department of Structural Biology Research Center (SBRC), Research Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Flanders Institute for Biotechnology (VIB), Brussels, Belgium
⁹Department of Internal Medicine, Ghent University, Belgium
^*These authors have contributed equally to this work

Published: April 27, 2018

This article has been corrected: The correct author affiliation is given below:

Mérédis Favreau^1,4,9 and Magdalena Radwanska^3,4

⁹Department of Internal Medicine, Ghent University, Belgium

Original article: Oncotarget. 2017; 8:52016-52025. DOI: https://doi.org/10.18632/oncotarget.18152.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25336

Publication Alerts

Corrections:

Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells